Anna Lubking

Lund, M, Sweden

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications

Central nervous system involvement and relapse in adult acute lymphoblastic leukaemia-a population-based analysis in 2007-2022.

Central nervous system involvement and relapse in adult acute lymphoblastic leukaemia-a population-based analysis in 2007-2022.

Journal: British journal of haematology
Published: July 12, 2025

High Prevalence of Psychological Symptoms, Sexual Dysfunction, and Prolonged Medical Leave Two Years After Acute Leukemia Diagnosis-Patient Reported Outcome in Sweden.

High Prevalence of Psychological Symptoms, Sexual Dysfunction, and Prolonged Medical Leave Two Years After Acute Leukemia Diagnosis-Patient Reported Outcome in Sweden.

Journal: EJHaem
Published: May 11, 2025

The impact of Covid-19 in patients with chronic myeloid leukemia-a nationwide population-based study.

The impact of Covid-19 in patients with chronic myeloid leukemia-a nationwide population-based study.

Journal: Leukemia
Published: January 24, 2023

IFN-α with dasatinib broadens the immune repertoire in patients with chronic-phase chronic myeloid leukemia.

IFN-α with dasatinib broadens the immune repertoire in patients with chronic-phase chronic myeloid leukemia.

Journal: The Journal of clinical investigation
Published: July 06, 2021

Long-term tolerability and efficacy after initial PegIFN-α addition to dasatinib in CML-CP: Five-year follow-up of the NordCML007 study.

Long-term tolerability and efficacy after initial PegIFN-α addition to dasatinib in CML-CP: Five-year follow-up of the NordCML007 study.

Journal: European journal of haematology
Published: April 05, 2021

Successful tyrosine kinase inhibitor discontinuation outside clinical trials - data from the population-based Swedish chronic myeloid leukaemia registry.

Successful tyrosine kinase inhibitor discontinuation outside clinical trials - data from the population-based Swedish chronic myeloid leukaemia registry.

Journal: British journal of haematology
Published: November 30, 2020

Molecular status 36 months after TKI discontinuation in CML is highly predictive for subsequent loss of MMR-final report from AFTER-SKI.

Molecular status 36 months after TKI discontinuation in CML is highly predictive for subsequent loss of MMR-final report from AFTER-SKI.

Journal: Leukemia
Published: November 09, 2020

Introducing patient-reported outcome in the acute leukemia quality registries in Sweden.

Introducing patient-reported outcome in the acute leukemia quality registries in Sweden.

Journal: European journal of haematology
Published: November 27, 2019

Survival in adult acute lymphoblastic leukaemia (ALL): A report from the Swedish ALL Registry.

Survival in adult acute lymphoblastic leukaemia (ALL): A report from the Swedish ALL Registry.

Journal: European journal of haematology
Published: March 21, 2019

Allogeneic stem cell transplantation for chronic myeloid leukemia in the TKI era: population-based data from the Swedish CML registry.

Allogeneic stem cell transplantation for chronic myeloid leukemia in the TKI era: population-based data from the Swedish CML registry.

Journal: Bone marrow transplantation
Published: September 20, 2018

Isolated myelosarcoma is characterized by recurrent NFE2 mutations and concurrent preleukemic clones in the bone marrow.

Isolated myelosarcoma is characterized by recurrent NFE2 mutations and concurrent preleukemic clones in the bone marrow.

Journal: Blood
Published: December 02, 2017

Increased proportion of mature NK cells is associated with successful imatinib discontinuation in chronic myeloid leukemia.

Increased proportion of mature NK cells is associated with successful imatinib discontinuation in chronic myeloid leukemia.

Journal: Leukemia
Published: August 24, 2016
Showing 1-12 of 16

Last Updated: 09/26/2026